Genome Editing ETF
- 886.684
- -26.230-2.87%
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Cathie Wood Sells 36K Shares of Her Own Bitcoin Backed ARKB to Start off 2025
Cathie Wood Meets Moomoo: Exclusive Insights for Our Community
Cathie Wood's Ark Invest Books Profits On Hot AI Stock Palantir, Sells Bitcoin ETF Shares As BTC Starts 2025 On A Positive Note
WisdomTree BioRevolution Fund Declares Annual Distribution of $0.1071
IShares Genomics Immunology and Healthcare ETF Declares $0.1111 Dividend
Cathie Wood's Ark Invest Trims Tesla Exposure Amid Searing Rally, Sells $21.8M Worth Of Stock — Bets On This AI Medical Company
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
Hedge Funds Were Net Buyers of Financials, Healthcare for Week: Goldman Sachs
Continuously High Dispersion in the Markets Could Make It a 'Picker's Market'
ARKK's Holdings Ranked by SA Quant Grades
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
The Most Overbought and Oversold Global Sectors - Utilities Most OB
Why Is Medpace Stock Diving On Tuesday?
Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock
Capitulation in Biotech Is Near, as Well as a Rally – Piper Sandler
Why Recursion Is Getting Love as an AI and Drug Discovery Top Pick